CooperVision stock is listed on Nasdaq, and Citigroup has issued a price objective for the company.
9 reports, 4 independent
Updated Oct 9
Gone quiet
- Reports
- 9
- Developments
- 3
- Repetition
- 78%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CooperVision stock is listed on Nasdaq, and Citigroup has issued a price objective for the company.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Goldman Sachs analyst targets affect CooperVision's stock perception on Nasdaq.1 source
- CooperCompanies shares traded on Nasdaq, and William Blair downgraded the stock while Al White serves as CEO.Sub-event
CooperVision lists on Nasdaq; Citigroup provides rating coverage.1 source
Keep exploring
The entities involved
-
CooperVision
company in Fairport, United States
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
Citigroup
American investment bank and financial services corporation
Related events
- CleanSpark traded on the Nasdaq stock exchange, and Citigroup provided research reports and ratings.
- Citigroup and Morgan Stanley provided price target and rating updates for Altria on November 4, 2026.
- Morgan Stanley and Citigroup raised price objectives on Amgen shares, with MarketBeat reporting the consensus rating.
- Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.
- Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.